Dry Age-related Macular Degeneration

CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: PRIMA US-Feasibility Study in Atrophic Dry AMD [NA]

The PRIMA US feasibility study for atrophic dry age-related macular degeneration is currently active but not recruiting.

CLINICAL_TRIALS trial_result · 2026-02-24

Clinical Trial Update: Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration [NA]

This entry notes the completion of a clinical trial evaluating subtenon platelet-rich plasma (PRP) injections for geographic atrophy in dry …

CLINICAL_TRIALS trial_result · 2025-10-15

Clinical Trial Update: Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) [Phase 1, Phase 2]

Phase 1/2 clinical trial to assess the safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degener…

CLINICAL_TRIALS trial_result · 2025-08-24

Clinical Trial Update: FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD [Phase 1, Phase 2]

The FOCUS study (GT005) in dry age-related macular degeneration was terminated in Phase 1/2, and results have been posted.

CLINICAL_TRIALS trial_result · 2025-07-10

Clinical Trial Update: HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 [Phase 2]

A Phase II study evaluating two doses of GT005 for dry age-related macular degeneration was terminated; results have been posted.

CLINICAL_TRIALS trial_result · 2025-06-24

Clinical Trial Update: Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) [NA]

This clinical trial update notes the completion of a study evaluating microcurrent stimulation therapy for dry, nonexudative age-related mac…

CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration [Phase 2]

Phase 2 trial update of an Encapsulated Cell Technology implant for atrophic (dry) age-related macular degeneration; the study has completed…

CLINICAL_TRIALS trial_result · 2025-01-07

Clinical Trial Update: QA102 Phase II Study in Subjects With Dry AMD [Phase 2]

QA102 Phase II trial in Dry age-related macular degeneration has completed.

CLINICAL_TRIALS trial_result · 2024-10-31

Clinical Trial Update: Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration [Phase 1, Phase 2]

A Phase 1/2 trial evaluated the safety and tolerability of sub-retinal transplantation of MA09-hRPE cells derived from human embryonic stem …

CLINICAL_TRIALS trial_result · 2023-12-15

Clinical Trial Update: Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study [Phase 3]

Pilot prospective cohort study investigating the effects of antiplatelet and antioxidant agents on drusen progression in dry age-related mac…

CLINICAL_TRIALS trial_result · 2023-05-11

Clinical Trial Update: Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration [Phase 2, Phase 3]

A Phase 2/Phase 3 trial update for Zimura in geographic atrophy due to dry age-related macular degeneration. The study is completed and resu…

CLINICAL_TRIALS trial_result · 2023-01-11

Clinical Trial Update: CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration [Phase 3]

Phase 3 trial update for CB-PRP in retinitis pigmentosa and dry age-related macular degeneration (AREDS) has been completed.

CLINICAL_TRIALS trial_result · 2020-07-08

Clinical Trial Update: A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration [Phase 2]

Phase 2 trial evaluating safety and exploratory efficacy of 1.0 mg Luminate (Alg-1001) for non-exudative (dry) age-related macular degenerat…

CLINICAL_TRIALS trial_result · 2019-12-10

Clinical Trial Update: A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration [Phase 2]

Phase 2 clinical trial evaluating ocular blood flow effects of unoprostone isopropyl in adults with dry age-related macular degeneration has…

CLINICAL_TRIALS trial_result · 2018-02-01

Clinical Trial Update: Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases [Phase 1, Phase 2]

Clinical trial update on subretinal transplantation of retinal pigment epitheliums for dry age-related macular degeneration (Phase 1/Phase 2…

CLINICAL_TRIALS trial_result · 2018-01-31

Clinical Trial Update: Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells [Phase 1, Phase 2]

A study evaluating retinal pigment epithelium derived from human embryonic stem cells for dry age-related macular degeneration in Phase 1/2.

CLINICAL_TRIALS trial_result · 2013-05-03

Clinical Trial Update: Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration [Phase 1]

A Phase 1 trial evaluating weekly Copaxone vaccination for dry age-related macular degeneration has been suspended.

CLINICAL_TRIALS trial_result · 2012-05-04

Clinical Trial Update: Transcorneal Electrical Stimulation Therapy for Retinal Disease [NA]

Okuvision GmbH's transcorneal electrical stimulation therapy trial for retinal diseases has completed. Conditions studied include retinitis …

CLINICAL_TRIALS trial_result · 2010-06-22

Clinical Trial Update: Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration [Phase 2]

A Phase 2 study evaluating fenretinide for geographic atrophy in dry age-related macular degeneration has completed.

Top drugs studied for this disease